| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.36 | 0.0008 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |